Heparin‐induced thrombocytopenia: pathogenesis and management
Tóm tắt
Từ khóa
Tài liệu tham khảo
Amiral J., 1996, Presence of autoantibodies to interleukin‐8 or neutrophil‐activating peptide‐2 in patients with heparin‐associated thrombocytopenia, Blood, 88, 410, 10.1182/blood.V88.2.410.bloodjournal882410
Carlsson L.E., 1998, Heparin‐induced thrombocytopenia: new insights into the impact of the FcγRIIa–R–H131 polymorphism, Blood, 92, 1526, 10.1182/blood.V92.5.1526
Chong B.H., 1994, Plasma P‐selectin is increased in thrombotic consumptive platelet disorders, Blood, 83, 1535, 10.1182/blood.V83.6.1535.1535
Denomme G.A., 2001, Heparin‐induced Thrombocytopenia, 189
Eichler P., 1999, First workshop for detection of heparin‐ induced antibodies: validation of the heparin‐induced platelet activation (HIPA) test in comparison with a PF4/heparin ELISA, Thrombosis and Haemostasis, 81, 625, 10.1055/s-0037-1614536
Eichler P., 2000, Antihirudin antibodies in patients with heparin‐induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance, Blood, 96, 2373, 10.1182/blood.V96.7.2373
Eichler P., 2002, Results of the third prospective study of treatment with lepirudin in patients with heparin‐induced thrombocytopenia (HAT), Blood, 100, 704a
Fischer K.G., 2001, Heparin‐induced Thrombocytopenia, 409
Francis J.L. Drexler A. Gwyn G.&Moroose R.(2003b)Bivalirudin a direct thrombin inhibitor in the treatment of heparin‐induced thrombocytopenia.Journal of Thrombosis and Haemostasis(in press).
Greinacher A., 2001, Heparin‐induced Thrombocytopenia, 291
Greinacher A., 1994, Heparin‐associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4–heparin complex as the major antigen, Thrombosis and Haemostasis, 71, 247
Greinacher A., 1994, Heparin‐associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation: a possible new indication of high dose i.v. IgG, Thrombosis and Haemostasis, 71, 641, 10.1055/s-0038-1642496
Greinacher A., 2000, Heparin‐induced thrombocytopenia with thromboembolic complications: meta‐analysis of two prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range, Blood, 96, 846, 10.1182/blood.V96.3.846
Hong A.P. Cook D.J. Sigouin C.S.&Warkentin T.E.(2003)Central venous catheters and upper‐extremity deep‐vein thrombosis complicating immune heparin‐induced thrombocytopenia.Blood 101 3049–3051.
Kwaan H.C., 1999, Endothelial cell hyperplasia contributes to thrombosis in heparin‐induced thrombocytopenia, Seminars in Thrombosis and Hemostasis, 25, 23
Lee D.H., 2001, Heparin‐induced Thrombocytopenia, 87
Lee D.H., 1998, Factor V Leiden and thrombotic complications in heparin‐induced thrombocytopenia, Thrombosis and Haemostasis, 79, 50, 10.1055/s-0037-1614218
Lewis B.E. Wallis D.E. Leya F. Hursting M.J.&Kelton J.G.(2003)Argatroban anticoagulation in patients with heparin‐induced thrombocytopenia.Archives of Internal Medicine(in press).
Lubenow N., 2002, Results of a large drug monitoring program confirms the safety and efficacy of Refludan (lepirudin) in patients with immune‐mediated heparin‐induced thrombocytopenia, Blood, 100, 502a
Lubenow N., 2002, Meta‐analysis of three prospective studies of lepirudin in the prevention of thrombosis in patients with heparin‐induced thrombocytopenia, Blood, 100, 501a
McIntyre K., 2001, Heparin‐ induced Thrombocytopenia, 445
Magnani H.N., 1993, Heparin‐induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172), Thrombosis and Haemostasis, 70, 554, 10.1055/s-0038-1649626
Magnani H.N., 1997, New Anticoagulants for the Cardiovascular Patient, 487
Newman P.M., 2000, Heparin‐induced thrombocytopenia: new evidence for the dynamic binding of purified anti‐PF4–heparin antibodies to platelets and the resultant platelet activation, Blood, 96, 182, 10.1182/blood.V96.1.182
Newman P.M., 1998, Heparin‐induced thrombocytopenia: IgG binding to PF4–heparin complexes in the fluid phase and cross‐reactivity with low molecular weight heparin and heparinoid, Thrombosis and Haemostasis, 80, 292, 10.1055/s-0037-1615190
Poetzsch B., 2001, Heparin‐induced Thrombocytopenia, 429
Polgár J., 1998, Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera form heparin‐induced thrombocytopenia patients, Blood, 91, 549, 10.1182/blood.V91.2.549
Pötzsch B., 1997, Monitoring of r‐hirudin anticoagulation during cardiopulmonary bypass assessment of the whole blood ecarin clotting time, Thrombosis and Haemostasis, 77, 920, 10.1055/s-0038-1656078
Ranze O., 2000, The use of low‐molecular‐weight heparins in heparin‐induced thrombocytopenia (HIT): a cohort study, Annals of Hematology, 79, P198
Sheth S.B., 2001, Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin, Thrombosis and Haemostasis, 85, 435, 10.1055/s-0037-1615601
Srinivasan A.F. Rice L. Bartholomew J.R. Rangaswamy C. La Perna L. Thompson J.E. Murphy S.&Baker K.R.(2003)Warfarin‐induced skin necrosis and venous limb gangrene in the setting of heparin‐induced thrombocytopenia.Archives of Internal Medicine(in press).
Suh J.S., 1998, Antibodies from patients with heparin‐induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4, Blood, 91, 916, 10.1182/blood.V91.3.916
Tardy B., 1999, Lower limb veins should be systematically explored in patients with isolated heparin‐induced thrombocytopenia, Thrombosis and Haemostasis, 82, 1199, 10.1055/s-0037-1614355
Warkentin T.E., 1996, Danaparoid (Orgaran) for the treatment of heparin‐induced thrombocytopenia (HIT) and thrombosis: effects on in vivo thrombin and cross‐linked fibrin generation, and evaluation of the clinical significance of in vitro cross‐reactivity (SR) of danaparoid for HIT‐IgG, Blood, 88, 626a
Warkentin T.E., 2001, Heparin‐induced Thrombocytopenia, 271
Warkentin T.E., 2001, Heparin‐induced Thrombocytopenia, 1
Warkentin T.E., 2001, Heparin‐induced Thrombocytopenia, 43
Warkentin T.E., 2001, Heparin‐induced thrombocytopenia: yet another treatment paradox?, Thrombosis and Haemostasis, 85, 947, 10.1055/s-0037-1615945
Warkentin T.E., 2002, Platelet count monitoring and laboratory testing for heparin‐induced thrombocytopenia, Archives of Pathology and Laboratory Medicine, 126, 1415, 10.5858/2002-126-1415-PCMALT
Warkentin T.E., 2002, Heparin‐induced thrombocytopenia, Current Hematology Reports, 1, 63
Warkentin T.E., 2002, Heparin‐induced thrombocytopenia for the anesthesiologist, Canadian Journal of Anesthesia, 49, s36
Warkentin T.E., 2002, Heparin‐induced thrombocytopenia, part 2: clinical course and treatment, Journal of Critical Illness, 17, 215
Warkentin T.E.&Bernstein R.A.(2003)Delayed‐onset heparin‐induced thrombocytopenia and cerebral thrombosis following a single administration of unfractionated heparin.New England Journal of Medicine(in press).
Warkentin T.E., 2001, Heparin‐induced Thrombocytopenia, 231
Warkentin T.E.&Heddle N.M.(2003)Laboratory diagnosis of immune heparin‐induced thrombocytopenia.Current Hematology Reports 2 148–157.
Warkentin T.E., 2002, Gender and risk of immune heparin‐induced thrombocytopenia, Blood, 100, 17a
Warkentin T.E., 1992, Determinants of donor platelet variability when testing for heparin‐induced thrombocytopenia, Journal of Laboratory and Clinical Medicine, 120, 371